Bright Light Therapy in Individuals with Multiple Sclerosis

In a study involving 27 individuals with multiple sclerosis (MS), researchers planned to investigate the effects of bright light therapy on sleep disturbances over a 2-week follow-up period, focusing on the number of adverse events. However, no results have been posted yet, meaning the outcomes are still unknown.

Tags: #Other
Most relevant to: —
Source: Read original source

This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.

Why it matters

Sleep disturbances are common in MS patients and significantly impact their quality of life. Understanding whether bright light therapy can alleviate these disturbances is crucial for improving patient well-being.

What this does not prove

The study lacks posted results, and details about planned enrolment and endpoints do not provide information on the actual findings.

Next milestone

No next milestone was established from the available source.

Study facts

Study design: Not reported
Participants / samples: 27 · actual
Randomised: Not reported
Controlled: Not reported
Primary endpoint met: Not reported
Relevant MS type: All
Publication date: Not reported
Evidence reviewed: Trial registry record
Regulatory approval: No
Research areas: Other

Original sources

Trial registrationBright Light Therapy for Sleep Disturbance in People With Multiple Sclerosis ↗

Supporting passages (11)

subjects"Multiple Sclerosis"

sample size"count": 27

sample size basis"type": "ACTUAL"

regulatory approval"isFdaRegulatedDrug": false, "isFdaRegulatedDevice": false

research categoriesPrior research supports the use of timed bright light therapy (LT) as one such approach for insomnia and sleepiness in those with sleep disorders or other neurologic diseases.

relevant ms types"conditions": [ "Multiple Sclerosis" ]

intervention"interventionNames": [ "Other: Light therapy" ]

primary endpoint"measure": "Number of adverse events"

follow up"timeFrame": "2 weeks"

findings"briefSummary": "Sleep disturbance is common in people with multiple sclerosis (MS) and contributes to diminished quality of life.

limitationsNo results are posted. Planned enrolment and endpoints are not findings.

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.